|
Posters,
Presentations & Publications 2008 2007 2006 2005 2004 2003 2002 2001 2000 1996-1999 Wolff SC, Brubaker K, Navratil T, Fulcher EH, Lankford JR and Boyer JL. Muscarinic receptor antagonism by marketed oral and topically applied antihistamines. Poster presented at the American Academy of Optometry (AAO) 2006 Annual Meeting. 2006 December 7-10; Denver, Colorado, USA. Poster in PDF Brubaker K, Wright RC, Boyer JL. Persistent and insurmountable inhibition of the histamine H1 receptor activity by epinastine. Poster presented at the 2006 American College of Allergy, Asthma, & Immunology (ACAAI). 2006 November 9-15; Philadelphia, Pennsylvania, USA. Deterding R, Milla C, Barnes M, Engels J, Koenig J, Williams C, Gorden J, Mathews D, Smiley L. Safety and tolerability of denufosol inhalation solution: results of a 28-day phase 2 study in 5-7 year old patients with CF. Poster presented at the 2006 North American Cystic Fibrosis Conference. 2006 November 2-5; Denver, Colorado, USA. Poster in PDF Yerxa BJ, Brazzell RK, Kellerman DJ, Schaberg AE, Durham TA. Mechanism and Clinical Overview of Diquafosol Tetrasodium, a P2Y2 Agonist, For Dry Eye Disease. Powerpoint presentation by Dr. RK Brazzell at the XVII International Congress of Eye Research. 2006 October 29–November 3; Buenos Aires, Argentina. Abstract in PDF Ezzell JA, Hansen MR, Anderson SA, Peterson WM, Eckert WA. Brief corneal inflammation produces delayed hyperalgesia and trigeminal dorsal horn sensitization. Poster presented at the Society for Neuroscience Annual Meeting - Neuroscience 2006. 2006 October 14-18; Atlanta, Georgia, USA. Poster in PDF Mega B, Crean CS, Bode AP, Nifong LW, Sun YS, K Salleng, Chitwood R, Boyer JL. A reversible ADP platelet receptor antagonist maintains graft patency and preserves platelet function after cardiopulmonary bypass and CABG in a canine model. Poster presented at the Society for the Advancement of Blood Management Annual Meeting. 2006 September 15-17; Jersey City, New Jersey, USA. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006 September; 58(3):281-341. Smiley L, Rossi A, Mathews D, Engels J, Schaberg A, Kellerman D, Shaffer C, Deterding R. Denufosol tetrasodium inhalation solution: results from two phase 2 trials in CF patients with mild to moderate lung disease. Powerpoint presentation by Dr. Lynn Smiley and Poster presented at the 29th European Cystic Fibrosis Conference. 2006 June 15-18; Copenhagen, Denmark. Presentation in PDF Poster in PDF Crean CS, Boyer JL. The disposition, metabolism and elimination of INS50589, a potent, selective and reversible P2Y12 receptor antagonist in rats. Poster presented at the 9th European International Society for the Study of Xenobiotics (ISSX) Meeting. 2006 June 4-7; Manchester, UK. Poster in PDF Brubaker K, Yerxa BR, Boyer JL. In Vitro analysis of the antagonism of the histamine H1 receptor by epinastine: A kinetic comparison with other marketed compounds. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting. 2006 April 30 - May 4; Fort Lauderdale, Florida, USA. Poster in PDF Eckert
WA, Ezzell JA, Durham T, Lan L, Metzler AD, Hansen MR, Ezzell JA, Peterson WM, Crean CS, Vittitow JL. Ocular Pharmacokinetics in aqueous and vitreous humor of a single intravitreal injection of denufosol tetrasodium (INS37217) in Dutch belted rabbits. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting. 2006 April 30 - May 4; Fort Lauderdale, Florida, USA. Poster in PDF Nichols KK, King-Smith PE, Nichols JJ, and Kellerman D. Tear film thickness and thinning rate following a six-week trial of 2% diquofosol tetrasodium vs. placebo in dry eye patients. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting. 2006 April 30 - May 4; Fort Lauderdale, Florida, USA. Poster in PDF Ousler III GW, Kellerman D, Durham T, Brazzell K, Kennedy K, Abelson MB. An association between central corneal staining and dry eye symptomatology. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting. 2006 April 30 - May 4; Fort Lauderdale, Florida, USA. Poster in PDF Vittitow JL, Eckert WA, Ezzell JA, Verhoeven RS, Peterson WM, Anderson SA. An experimental model of chronic dry eye combining extraorbital lacrimal gland excision and subcutaneous scopolamine in the rat. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting. 2006 April 30 - May 4; Fort Lauderdale, Florida, USA. Poster in PDF Bourdon DM, Mahanty SK, Jacobson KA, Boyer JL, Harden TK. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets. J Thromb Haemost. 2006 April;4(4):861-868. Johnson FL, Boyer JL, Leese PT, Durham T, Crean CS, Krishnamoorthy R, Kellerman DJ. Pharmacological evaluation of a novel, rapidly reversible intravenous platelet P2Y12 ADP receptor antagonist, INS50589 in healthy volunteers. J Am Coll Cardiol. 2006; 47(4 Suppl B): 51. Johnson FL, Boyer JL, Leese PT, Durham T, Crean CS, Krishnamoorthy R, Kellerman DJ. Pharmacological evaluation of a novel, rapidly reversible intravenous platelet P2Y12 ADP receptor antagonist, INS50589 in healthy volunteers. Poster presented at the American College of Cardiology 55th Annual Meeting. 2006 March 11-14; Atlanta, Georgia, USA. Poster in PDF Crean CS, Bode AP, Sun Y-S, Nifong W, Cowlen M, Anderson S, Peterson W, Boyer JL. Antiplatelet treatment with P2Y12 receptor antagonist decreases blood loss in a canine CABG model with cardiopulmonary bypass. J Am Coll Cardiol 2006; 47(4 Suppl A): 191A. Crean CS, Bode AP, Sun Y-S, Nifong W, Cowlen M, Anderson S, Peterson W, Boyer JL. Antiplatelet treatment with P2Y12 receptor antagonist decreases blood loss in a canine CABG model with cardiopulmonary bypass. Poster presented at the American College of Cardiology 55th Annual Meeting. 2006 March 11-14; Atlanta, Georgia, USA. Poster in PDF Cowlen M, Crean C, Krishnamoorthy R, Richards L, Watson P, Boyer JL. Cardiopulmonary safety and toxicology evaluation of INS50589, a reversible P2Y12 receptor antagonist with anti-platelet aggregation activity, administered by continuous intravenous infusion in beagle dogs. Poster presented at the Society of Toxicology Annual Meeting; 2006 March 5-9; San Diego, California, USA.
Page last updated: 23-Jun-2008
|
|
|
Note:
If you are having problems opening
any of the Posters or Presentations in PDF, please refresh
your page to clear out the attempt and then, with your mouse hovering
over the link to the PDF document, right click and choose Save Target
As, choose a location on your hard drive to save the document and click
save. Once the download is complete you will be given a choice to Open,
Open Folder or Close. Click Open and the PDF should open immediately.
If you continue to have problems, please conact info@inspirepharm.com.
